EUVIMEDEUVIMED entdecken
Crossref

Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes

Masaki Tsuji iD, Jignesh K Patel, Michelle M Kittleson iD, David H Chang, Evan P Kransdorf iD, Andriana P Nikolova, Lily K Stern iD, Mason Lee, Jon A Kobashigawa

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Masaki Tsuji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Reoperation, Postoperative Complications. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Mochida Memorial Foundation for Medical and Pharmaceutical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart re‐transplantation (re‐HT) is the last treatment option for end‐stage graft failure, with cases due to severe cardiac allograft vasculopathy (CAV) showing a better prognosis compared to other indications. However, the effects of restrictive cardiac allograft physiology (RCP), classified as severe CAV, on re‐HT outcomes remain unclear.

Methods

We assessed patients with severe CAV who underwent re‐HT between 2010 and 2024. RCP was defined as symptomatic heart failure with restrictive echocardiographic values (E‐to‐A velocity ratio >2 and deceleration time 12 mmHg, pulmonary capillary wedge pressure >25 mmHg, and cardiac index

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationGraft RejectionReoperationPostoperative ComplicationsHeart FailureHumansFemaleMaleMiddle AgedPrognosisFollow-Up StudiesRetrospective StudiesSurvival RateGraft SurvivalRisk FactorsAllograftsAdult

Autor:innen und Institutionen

  • Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

ORCID-Profile: Masaki Tsuji, Michelle M Kittleson, Evan P Kransdorf, Lily K Stern

Förderung

  • Mochida Memorial Foundation for Medical and Pharmaceutical Research

Zitieren

APA

Tsuji, M., Patel, J. K., Kittleson, M. M., Chang, D. H., Kransdorf, E. P., Nikolova, A. P., Stern, L. K., Lee, M., & Kobashigawa, J. A. (2025). Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes. Clinical Transplantation. https://doi.org/10.1111/ctr.70124

Vancouver

Tsuji M, Patel JK, Kittleson MM, Chang DH, Kransdorf EP, Nikolova AP, et al. Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes. Clinical Transplantation. 2025. doi:10.1111/ctr.70124

BibTeX
@article{Tsuji2025,
  author = {Tsuji, Masaki and Patel, Jignesh K and Kittleson, Michelle M and Chang, David H and Kransdorf, Evan P and Nikolova, Andriana P and Stern, Lily K and Lee, Mason and Kobashigawa, Jon A},
  title = {Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70124}
}
Kostenlos starten →